Login to Your Account



Pharma: Clinic Roundup


Wednesday, September 5, 2012
• Boehringer Ingelheim GmbH, of Ingelheim, Germany, reported Phase III data showing tiotropium delivered by the Respimat Soft Mist Inhaler demonstrated significant improvements in lung function in adults with asthma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription